Cardiovascular Risk Factors in Transgender People after Gender-Affirming Hormone Therapy

Introduction: In the last decade, healthcare for the transgender population has increased considerably in many countries thanks to depathologization movements and the easier accessibility of medical assistance. The age at which they request to start gender-affirming hormones (GAHs) is increasingly y...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Toscano, Esteban, Domínguez-Riscart, Jesús, Larrán-Escandón, Laura, Mateo-Gavira, Isabel, Aguilar-Diosdado, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573211/
https://www.ncbi.nlm.nih.gov/pubmed/37834785
http://dx.doi.org/10.3390/jcm12196141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573211/
https://www.ncbi.nlm.nih.gov/pubmed/37834785
http://dx.doi.org/10.3390/jcm12196141

Ejemplares similares